---
title: "Multicomponent vaccination for seasonal influenza and COVID-19 in adults"
id: "pubmed-42790130"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42790130"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42790130/"
doi: "10.1016/j.vaccine.2026.129082"
published_at: "2026-11-14T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Multicomponent vaccination for seasonal influenza and COVID-19 in adults
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42790130
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42790130/)
- **DOI:** [10.1016/j.vaccine.2026.129082](https://doi.org/10.1016%2Fj.vaccine.2026.129082)
- **Published At:** 2026-11-14T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Seasonal **influenza** and **SARS-CoV-2** continue to cause significant hospitalizations and deaths, especially in infants and older adults, and remain major contributors to global morbidity and mortality. - Effective vaccines exist for both **influenza** and **COVID-19**, but uptake is below WHO-recommended levels; increasing coverage is a priority to protect vulnerable groups and reduce health-system strain. - The WHO recommends co-administration of influenza and COVID-19 vaccines when epidemiologically appropriate; a **multicomponent vaccine** could extend that strategy by combining antigens into a single product. - Potential benefits described in the review include simplified dosing schedules, fewer missed opportunities for vaccination, higher overall coverage, and reductions in disease burden and healthcare costs. - Healthcare workers in surveyed studies preferred combination vaccines over separate products and reported they would likely recommend them; consumer interest in combination products was also reported. - Key implementation considerations identified by the authors include timing of administration and appropriate strain selection for both influenza and SARS-CoV-2; specifics on optimal timing were not reported in the abstract. - The review summarizes multicomponent candidates currently under clinical evaluation; the abstract does not provide detailed trial designs, dosing regimens, or efficacy results. - Challenges and hurdles to a multicomponent approach are discussed in the article; the abstract lists these topics but does not enumerate operational or regulatory barriers in detail. - Authors and affiliations include academic and industry contributors; conflicts of interest disclose employment and equity ties to Moderna Inc. for several authors and multiple consultancies and industry relationships for others. - The review concludes that promising candidates are in development and that a multicomponent adult immunization approach may strengthen protection against two major respiratory pathogens, while noting unresolved clinical and implementation questions.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42790130/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42790130%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42790130/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42790130/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42790130/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42790130/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42790130/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42790130/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42790130%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42790130%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42790130/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42790130/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42790130/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42790130/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0264-410X\(26\)00891-1 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42790130/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42790130/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42790130/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42790130/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42790130/#conflict-of-interest) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42790130/#similar) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42790130/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42790130/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42790130/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42790130/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42790130/#linkout) Title & authors Abstract Conflict of interest statement Similar articles Publication types MeSH terms Substances Related information LinkOut - more resources Review Vaccine Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Vaccine%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Vaccine%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42790130/) . 2026 Nov 14:93:129082. doi: 10.1016/j.vaccine.2026.129082. Epub 2026 Sep 25. # Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults [William Schaffner](https://pubmed.ncbi.nlm.nih.gov/?term=Schaffner+W&cauthor_id=42790130)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-1 "Department of Health Policy, Vanderbilt University Medical Center, 1211Medical Center Drive, Nashville, TN 37232, USA."), [Stefan Gravenstein](https://pubmed.ncbi.nlm.nih.gov/?term=Gravenstein+S&cauthor_id=42790130)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-2 "Division of Geriatrics and Palliative Medicine, Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA."), [Stephen Kissler](https://pubmed.ncbi.nlm.nih.gov/?term=Kissler+S&cauthor_id=42790130)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-3 "Department of Computer Science, University of Colorado Boulder, 2230 Colorado Avenue, Boulder, CO 80310, USA; BioFrontiers Institute, University of Colorado, 2230 Colorado Avenue, Boulder, CO 80310, USA."), [Oliver A Cornely](https://pubmed.ncbi.nlm.nih.gov/?term=Cornely+OA&cauthor_id=42790130)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-4 "Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases \(CECAD\), Faculty of Medicine, University of Cologne, Albertus-Magnus Platz, 50931 Cologne, Germany; Department of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology \(ECMM\), Faculty of Medicine, University Hospital Cologne, Kerpener Street 62, 50937 Cologne, German Center for Infection Research \(DZIF\), Partner Site Bonn-Cologne, Cologne, Germany."), [Darshan Mehta](https://pubmed.ncbi.nlm.nih.gov/?term=Mehta+D&cauthor_id=42790130)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-5 "Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA."), [Manuel García Cenoz](https://pubmed.ncbi.nlm.nih.gov/?term=Cenoz+MG&cauthor_id=42790130)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-6 "Preventive Medicine and Public Health, Public Health Institute of Navarra, Pamplona, Spain."), [Nevena Vicic](https://pubmed.ncbi.nlm.nih.gov/?term=Vicic+N&cauthor_id=42790130)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-5 "Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA."), [Deborah Rudin](https://pubmed.ncbi.nlm.nih.gov/?term=Rudin+D&cauthor_id=42790130)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#full-view-affiliation-7 "Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: Deborah.RudinVerp@modernatx.com.") Affiliations Expand ### Affiliations * 1 Department of Health Policy, Vanderbilt University Medical Center, 1211Medical Center Drive, Nashville, TN 37232, USA. * 2 Division of Geriatrics and Palliative Medicine, Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA. * 3 Department of Computer Science, University of Colorado Boulder, 2230 Colorado Avenue, Boulder, CO 80310, USA; BioFrontiers Institute, University of Colorado, 2230 Colorado Avenue, Boulder, CO 80310, USA. * 4 Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Albertus-Magnus Platz, 50931 Cologne, Germany; Department of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, University Hospital Cologne, Kerpener Street 62, 50937 Cologne, German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. * 5 Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. * 6 Preventive Medicine and Public Health, Public Health Institute of Navarra, Pamplona, Spain. * 7 Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: Deborah.RudinVerp@modernatx.com. * PMID: **42790130** * DOI: [ 10.1016/j.vaccine.2026.129082 ](https://doi.org/10.1016/j.vaccine.2026.129082) Item in Clipboard Review # Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults William Schaffner et al. Vaccine. 2026. Show details Display options Display options Format Abstract PubMed PMID Vaccine Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Vaccine%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Vaccine%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42790130/) . 2026 Nov 14:93:129082. doi: 10.1016/j.vaccine.2026.129082. Epub 2026 Sep 25. ### Authors [William Schaffner](https://pubmed.ncbi.nlm.nih.gov/?term=Schaffner+W&cauthor_id=42790130)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-1 "Department of Health Policy, Vanderbilt University Medical Center, 1211Medical Center Drive, Nashville, TN 37232, USA."), [Stefan Gravenstein](https://pubmed.ncbi.nlm.nih.gov/?term=Gravenstein+S&cauthor_id=42790130)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-2 "Division of Geriatrics and Palliative Medicine, Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA."), [Stephen Kissler](https://pubmed.ncbi.nlm.nih.gov/?term=Kissler+S&cauthor_id=42790130)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-3 "Department of Computer Science, University of Colorado Boulder, 2230 Colorado Avenue, Boulder, CO 80310, USA; BioFrontiers Institute, University of Colorado, 2230 Colorado Avenue, Boulder, CO 80310, USA."), [Oliver A Cornely](https://pubmed.ncbi.nlm.nih.gov/?term=Cornely+OA&cauthor_id=42790130)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-4 "Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases \(CECAD\), Faculty of Medicine, University of Cologne, Albertus-Magnus Platz, 50931 Cologne, Germany; Department of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology \(ECMM\), Faculty of Medicine, University Hospital Cologne, Kerpener Street 62, 50937 Cologne, German Center for Infection Research \(DZIF\), Partner Site Bonn-Cologne, Cologne, Germany."), [Darshan Mehta](https://pubmed.ncbi.nlm.nih.gov/?term=Mehta+D&cauthor_id=42790130)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-5 "Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA."), [Manuel García Cenoz](https://pubmed.ncbi.nlm.nih.gov/?term=Cenoz+MG&cauthor_id=42790130)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-6 "Preventive Medicine and Public Health, Public Health Institute of Navarra, Pamplona, Spain."), [Nevena Vicic](https://pubmed.ncbi.nlm.nih.gov/?term=Vicic+N&cauthor_id=42790130)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-5 "Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA."), [Deborah Rudin](https://pubmed.ncbi.nlm.nih.gov/?term=Rudin+D&cauthor_id=42790130)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42790130/#short-view-affiliation-7 "Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: Deborah.RudinVerp@modernatx.com.") ### Affiliations * 1 Department of Health Policy, Vanderbilt University Medical Center, 1211Medical Center Drive, Nashville, TN 37232, USA. * 2 Division of Geriatrics and Palliative Medicine, Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA. * 3 Department of Computer Science, University of Colorado Boulder, 2230 Colorado Avenue, Boulder, CO 80310, USA; BioFrontiers Institute, University of Colorado, 2230 Colorado Avenue, Boulder, CO 80310, USA. * 4 Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Albertus-Magnus Platz, 50931 Cologne, Germany; Department of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, University Hospital Cologne, Kerpener Street 62, 50937 Cologne, German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. * 5 Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. * 6 Preventive Medicine and Public Health, Public Health Institute of Navarra, Pamplona, Spain. * 7 Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: Deborah.RudinVerp@modernatx.com. * PMID: **42790130** * DOI: [ 10.1016/j.vaccine.2026.129082 ](https://doi.org/10.1016/j.vaccine.2026.129082) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Seasonal influenza and SARS-CoV-2 are respiratory viruses that represent a global health concern, causing substantial numbers of hospitalizations and mortality, particularly among high-risk groups, including infants and older adults. Together these associated respiratory diseases and related complications are among the leading causes of morbidity and mortality. Although effective vaccines are available for protection against influenza and COVID-19, vaccine uptake remains below the levels recommended by the World Health Organization (WHO). Increasing vaccination coverage is critical for protecting vulnerable populations and reducing strain on healthcare systems. To improve vaccine uptake, the WHO recommends co-administering influenza and COVID-19 vaccines when epidemiologically justified. A multicomponent vaccine approach in adults could go beyond the current co-administration approach, as it has the potential to streamline delivery, reduce missed vaccination opportunities, and enhance vaccine coverage among individuals at risk. This manuscript reviews the current evidence on multicomponent vaccination for protection against seasonal influenza and COVID-19. We summarize published literature on the potential public health impacts of a multicomponent vaccination approach, discuss associated challenges, and review multicomponent vaccines currently in development. The studies in this review highlight various potential benefits of a multicomponent approach, including simplified dosing, greater vaccination coverage, and reduced disease burden and costs. Healthcare workers expressed a preference for a combination vaccine over standalone influenza or COVID-19 vaccines, indicating a high likelihood of recommending it to patients. Consumers also showed strong interest. For multicomponent vaccination to succeed, key considerations include the optimal timing of administration and appropriate strain selection for both the influenza and SARS-CoV-2 viruses. Promising multicomponent influenza-COVID-19 vaccine candidates currently being evaluated in clinical trials may represent an important advancement in adult immunization strategy, and a meaningful opportunity to strengthen protection against two of the most consequential respiratory pathogens worldwide. **Keywords:** COVID-19; Influenza; Multicomponent vaccine; SARS-CoV-2. Copyright © 2026 Elsevier Ltd. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Deborah Rudin reports a relationship with Moderna Inc. that includes: employment and equity or stocks. Darshan Mehta is a former empolyee of Moderna Inc. Nevena Vicic reports a relationship with Moderna Inc. that includes: employment and equity or stocks. William Schaffner reports an honorarium for one CME event from Abbott Diagnostics. Stefan Gravenstein reports a relationship with AstraZeneca that includes: consulting or advisory. Stefan Gravenstein reports a relationship with GlaxoSmithKline LLC that includes: consulting or advisory, and grant support. Stefan Gravenstein reports a relationship with Icosavax, Inc. that includes: consulting or advisory. Stefan Gravenstein reports a relationship with Moderna Inc. that includes: consulting or advisory, and grant support. Stefan Gravenstein reports a relationship with Novavax Inc. that includes: consulting or advisory. Stefan Gravenstein reports a relationship with Pfizer that includes: consulting or advisory, and grant support. Stefan Gravenstein reports a relationship with Sanofi that includes: consulting or advisory, and gr
## Related Clinical Research

- [Mapping SARS-CoV-2 Nucleocapsid Escape Sites That Threaten Rapid Antigen Tests](https://medichelpline.com/clinical-feed/pubmed-42872825.md) (DOI: 10.1128/jvi.01001-26)
- [Epidemiologic Variability and Clinical Severity of Pediatric Influenza Across 11 Seasons](https://medichelpline.com/clinical-feed/pubmed-43035904.md) (DOI: 10.1097/INF.0000000000005470)
- [CDC: About 1 in 10 U.S. Adults Used GLP-1 Medications in 2025; Industry Demands WHO Audit](https://medichelpline.com/clinical-feed/stat-news-7-stat-pharmalittle-we-re-reading-about-glp-1-use-covid-19-vaccine-investment.md)
- [Maternal and Early-Life Obesity Impairs CD4+ T Cell Programming and Vaccine Responses](https://medichelpline.com/clinical-feed/nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine.md)
- [Palmar lactic acid links to reduced hand scaling and greater in vitro pathogen inactivation](https://medichelpline.com/clinical-feed/plos-one-12-associations-of-palmar-surface-lactic-acid-with-hand-scaling-and-in-vitro.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.